Australia's most trusted
source of pharma news
Posted 10 December 2024 PM
High-flying former Novartis executive, Mike Exton, has added another feather to his cap, named an Honorary Professor of Professional Practice in the Business School at the University of Newcastle where he completed his PhD.
No doubt he has plenty of career advice to share with up-and-coming undergraduates - he nabbed the role of CEO of Lexicon Pharmaceuticals in July after a stellar 13-year career at Novartis, finishing up there as Global Cardiovascular Therapeutic Area Head.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.